Ameresco, Inc.
NYSE:AMRCEngineering & Construction
+$1.15 today
- Market cap
- $1.21B
- Beta
- 2.57
- P/E (TTM)
- 47.8
- EPS (TTM)
- $0.60
Volume 0.60M
Average 0.61M
AMRC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Ameresco, Inc.NYSE: AMRC
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AMRC compares with its peers on the latest reported figures
- AMRC's LTM Mar 2026 research & development of $0 is the 3rd highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for AMRC, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $186.5M | -7.9% | +7.0% | 23.6% | |
| LTM Mar 2026 | $18.73M | -2.0% | -1.3% | 2.6% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
LGNLegence Corp. Class A Common stock | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Feb 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2025 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AMRC) | $0 | -7.9% | +2.8% | 0.0% | |
Competitors are the stored peer set for AMRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.82B | 1.37B | 1.77B | 1.93B |
| Cost of Revenue | 985.34M | 1.53B | 1.13B | 1.51B | 1.63B |
| Gross Profit | 230.36M | 290.83M | 246.43M | 256.09M | 304.01M |
| Gross Margin | 18.9% | 15.9% | 17.9% | 14.5% | 15.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 132.9M | 159.49M | 162.14M | 173.76M | 178.54M |
| Operating Expenses | 134.92M | 157.84M | 164.21M | 147.35M | 175.46M |
| Depreciation & Amortization | 46.58M | 54.28M | 65.91M | 89.21M | 104.27M |
| EBITDA | 141.93M | 190.63M | 150.39M | 194.8M | 237.18M |
| EBITDA Margin | 11.7% | 10.4% | 10.9% | 11.0% | 12.3% |
| Operating Income | 95.43M | 132.99M | 82.22M | 108.75M | 128.56M |
| Operating Margin | 7.9% | 7.3% | 6.0% | 6.1% | 6.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 17.21M | 30.63M | 46.21M | 71.65M | 87.94M |
| Other Income / Expenses | (17.29M) | (27.27M) | (43.95M) | (74.81M) | (83.58M) |
| Income Before Tax | 78.14M | 105.72M | 38.27M | 33.94M | 44.98M |
| Pre-Tax Margin | 6.4% | 5.8% | 2.8% | 1.9% | 2.3% |
| Income Tax Expense | (2.05M) | 7.17M | (25.64M) | (20M) | (11.7M) |
| Net Income | 70.46M | 94.93M | 62.47M | 56.76M | 44.28M |
| Net Margin | 5.8% | 5.2% | 4.5% | 3.2% | 2.3% |
| EPS (Basic) | 1.38 | 1.83 | 1.20 | 1.08 | 0.84 |
| EPS (Diluted) | 1.35 | 1.78 | 1.17 | 1.07 | 0.83 |
| Weighted Avg Shares | 50.86M | 51.84M | 52.14M | 52.38M | 52.68M |
| Weighted Avg Shares (Diluted) | 52.27M | 53.28M | 53.23M | 53.14M | 53.29M |
Ameresco, Inc.
NYSE:AMRC
Intrinsic Alpha fair value
Locked
Current Price
$22.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.